Argan Stock Down 8% in the Past Month: Should You Buy Now or Wait?
AGX's $2.8B backlog and debt-free balance sheet support growth, but project concentration and execution risks cloud the outlook.
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Yahoo